Intactis Bio consists of a proprietary neural tissue, brain machine interface, and biocomputation platform.
Intactis Bio has raised $250K in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Intactis Bio's investors include Nucleus Fund, rpv, Altitude Lab.
Intactis Bio is headquartered in Salt Lake City, United States.
Intactis Bio consists of a proprietary neural tissue, brain machine interface, and biocomputation platform.
Intactis Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intactis Bio — Funding & Investors." VCBacked, February 24, 2026, https://www.vcbacked.co/company/intactis-bio. Accessed August 14, 2026.
VCBacked. (2026). Intactis Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/intactis-bio
{{cite web |title=Intactis Bio — Funding & Investors |url=https://www.vcbacked.co/company/intactis-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated